Literature DB >> 29767596

Challenges of implementing personalized (precision) medicine: a focus on diabetes.

Adriana Fodor1, Eddy Karnieli2.   

Abstract

The concept of personalized (precision) medicine (PM) emphasizes the scientific and technological innovations that enable the physician to tailor disease prediction, diagnosis and treatment to the individual patient, based on a personalized data-driven approach. The major challenge for the medical systems is to translate the molecular and genomic advances into clinical available means. Patients and healthcare providers, the pharmaceutical and diagnostic industries manifest a growing interest in PM. Multiple stakeholders need adaptation and re-engineering for successful clinical implementation of PM. Drawing primarily from the field of 'diabetes', this article will summarize the main challenges to implementation of PM into current medical practice and some of the approaches currently being implemented to overcome these challenges.

Entities:  

Keywords:  diabetes; future medicine; personalized medicine; pharmacogenetic testing; precise medicine

Year:  2016        PMID: 29767596     DOI: 10.2217/pme-2016-0022

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  3 in total

1.  Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective.

Authors:  Enrico Capobianco
Journal:  Clin Transl Med       Date:  2017-07-25

2.  GLUT4-overexpressing engineered muscle constructs as a therapeutic platform to normalize glycemia in diabetic mice.

Authors:  Margarita Beckerman; Chava Harel; Inbal Michael; Amira Klip; Philip J Bilan; Emily J Gallagher; Derek LeRoith; Eli C Lewis; Eddy Karnieli; Shulamit Levenberg
Journal:  Sci Adv       Date:  2021-10-13       Impact factor: 14.136

Review 3.  THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.

Authors:  M Walid Qoronfleh; Lotfi Chouchane; Borbala Mifsud; Maryam Al Emadi; Said Ismail
Journal:  Life Sci Soc Policy       Date:  2020-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.